CVE-2026-15415Path traversal and arbitrary file write in the workflow linters of aws-healthomics-mcp-server
Updated under an hour ago ()
Does this affect you?
It affects aws-healthomics-mcp-server. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.
- CVSS
- 5.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N
- Weakness (CWE)
- CWE-23
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- AMZN
- NVD analysis
- Awaiting Analysis
- Record last updated
- Aug 11, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.